biospecimen__admin__batch_number	231.65.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	F5978E95-8F3B-4A8E-806F-8B01F7367EF5
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-EP-A3RK-11A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-EP-A3RK-11A-11
biospecimen__bio__bcr_sample_barcode	TCGA-EP-A3RK-11A
biospecimen__bio__biospecimen_barcode_bottom	0118957383
biospecimen__bio__day_of_creation	20
biospecimen__bio__day_of_shipment	30
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	03
biospecimen__bio__month_of_shipment	05
biospecimen__bio__plate_column	9
biospecimen__bio__plate_id	A22J
biospecimen__bio__plate_row	E
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.20
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2012
biospecimen__bio__year_of_shipment	2012
biospecimen__shared__bcr_patient_barcode	TCGA-EP-A3RK
biospecimen__shared__patient_id	A3RK
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	AF69F21B-BCFB-46E8-86C6-D36ADEE047CB
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	4.3
clinical__chol_lihc_shared__albumin_result_upper_limit	4.8
clinical__chol_lihc_shared__bilirubin_lower_limit	0.0
clinical__chol_lihc_shared__bilirubin_upper_limit	0.6
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_value	7
clinical__chol_lihc_shared__fibrosis_ishak_score	1,2 - Portal Fibrosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	Alcohol consumption
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	0.9
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.2
clinical__chol_lihc_shared__platelet_result_lower_limit	140
clinical__chol_lihc_shared__platelet_result_upper_limit	415
clinical__chol_lihc_shared__prothrombin_time_result_value	1.1
clinical__chol_lihc_shared__specimen_collection_method_name	Other (specify)
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.2
clinical__clin_shared__age_at_initial_pathologic_diagnosis	73
clinical__clin_shared__bcr_followup_barcode	TCGA-EP-A3RK-F40454
clinical__clin_shared__bcr_followup_uuid	6DF49976-00D4-4E6D-936F-D3101F557BF7
clinical__clin_shared__day_of_form_completion	20
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__history_prior_surgery_type_other	left hepatic lobectomy
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	5
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__platelet_result_count	234
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__tissue_prospective_collection_indicator	YES
clinical__clin_shared__tissue_retrospective_collection_indicator	NO
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2012
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2012
clinical__lihc_nte__new_tumor_event_liver_transplant	No
clinical__nte__additional_pharmaceutical_therapy	YES
clinical__nte__days_to_new_tumor_event_after_initial_treatment	320
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Liver
clinical__nte__new_neoplasm_event_type	Locoregional Recurrence
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	MX
clinical__shared_stage__pathologic_n	NX
clinical__shared_stage__pathologic_t	T3a
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	c61516d3-6c12-4b20-83c0-6c29a656d129
gdc__aliquots__concentration	0.16
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-EP-A3RK-11A-11R-A22J-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	a742c17e-4d80-43f7-8ac6-4fbeb8e5da85
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.79
gdc__analytes__analyte_id	961180a7-b93a-46e9-be6c-d02635b9ef4b
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	f15279dd-5d12-460b-9bd1-b4f95681ca65
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:49:30.029218-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	4ae6eea5-99dd-5ded-b2b7-93753c29d2c4
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	white
gdc__demographic__year_of_birth	1939
gdc__diagnoses__age_at_diagnosis	26985
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-26985.0
gdc__diagnoses__days_to_last_follow_up	363.0
gdc__diagnoses__diagnosis_id	2ef28518-924b-56a3-b02a-c0a32962c5fb
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage iiia
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	31.877288221184195
gdc__exposures__exposure_id	976b0b28-1fc0-5384-9864-0cecbcc68e4b
gdc__exposures__height	178.0
gdc__exposures__weight	101.0
gdc__file_id	8e9eab49-87c7-4f8b-aac5-bd518bbe4026
gdc__file_name	abd0c7a6-54da-4fa7-bbef-c09b851b051f.mirbase21.mirnas.quantification.txt
gdc__file_size	50328
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	ae29157bb3998d95b81b911d29740c02
gdc__portions__is_ffpe	false
gdc__portions__portion_id	4cdf063d-c1be-4252-9d24-211e1909a957
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	14
gdc__samples__initial_weight	880.0
gdc__samples__oct_embedded	false
gdc__samples__sample_id	13576f15-4fba-4ea4-b682-32271d2768b5
gdc__samples__sample_type	Solid Tissue Normal
gdc__samples__sample_type_id	11
gdc__slides__percent_lymphocyte_infiltration	3.0
gdc__slides__percent_monocyte_infiltration	1.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	1.0
gdc__slides__percent_normal_cells	80.0
gdc__slides__percent_stromal_cells	20.0
gdc__slides__percent_tumor_cells	0.0
gdc__slides__percent_tumor_nuclei	0.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	4e77b15f-eb57-4cf6-ba54-d83725325708
gdc__submitter_id	mirna_swap_dr11_375_MirnaExpression174c15f3-d688-4004-80a0-fc1d8a362692_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	EP
gdc__tissue_source_site__name	Christiana Healthcare
gdc__tissue_source_site__tissue_source_site_id	dbcb7cb8-b22c-5a78-9d41-b93e7eb08f05
gdc__treatments__treatment_id	3b1f506e-b45f-51a6-93ce-81c1b56520c0
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:11:05.471+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/c61516d3-6c12-4b20-83c0-6c29a656d129-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/c61516d3-6c12-4b20-83c0-6c29a656d129-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129699
manually_curated__local_md5	561adba7eb18472d7b0adf1c04bc62a4
manually_curated__opengdc_download_date	2018-10-16T17:12:02.000842+02:00
manually_curated__opengdc_file_md5	5366b31b805803658fffca3d01bda5c9
manually_curated__opengdc_file_size	50327
manually_curated__opengdc_id	c61516d3-6c12-4b20-83c0-6c29a656d129-meq
manually_curated__origin_file_size	129699
manually_curated__origin_last_modified_date	Tue Oct 16 17:30:00 CEST 2018
manually_curated__origin_md5	561adba7eb18472d7b0adf1c04bc62a4
manually_curated__tissue_status	normal
num	1881
